Stock Events

Stock Events

Invitae 

€0.000000
0
+€0.00+0% 00:00 Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

People Also Follow

This list is based on the watchlists of people on Stock Events who follow IV8.MU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Illumina
ILMN
Mkt Cap28.55B
Illumina provides sequencing and array-based solutions for genetic analysis, directly competing with Invitae's genetic testing services.
Guardant Health
GH
Mkt Cap22.27B
Guardant Health specializes in liquid biopsies and cancer diagnostics, overlapping with Invitae's offerings in genetic health screenings and diagnostics.
Myriad Genetics
MYGN
Mkt Cap569.52M
Myriad Genetics focuses on molecular diagnostic tests, including for cancer and mental health, directly competing with Invitae's genetic testing services.
Intellia Therapeutics
NTLA
Mkt Cap2.45B
Intellia Therapeutics is involved in CRISPR gene editing, a technology that could compete with traditional genetic testing services by offering potential cures.
Editas Medicine
EDIT
Mkt Cap560.14M
Editas Medicine works on gene editing using CRISPR, presenting a future competitive edge in genetic treatments against Invitae's diagnostic services.
CRISPR Therapeutics
CRSP
Mkt Cap5.92B
CRISPR Therapeutics is focused on developing gene-based medicines, which could rival Invitae's genetic testing by offering direct therapeutic solutions.
Pacific Biosciences of California
PACB
Mkt Cap521.81M
Pacific Biosciences offers long-read sequencing technologies, competing with Invitae in the genetic testing market by providing alternative or complementary technologies.
Bionano Genomics
BNGO
Mkt Cap13.2M
Bionano Genomics provides genomic analysis tools, competing with Invitae in the structural variant detection and genetic analysis market.
Thermo Fisher Scientific
TMO
Mkt Cap194.52B
Thermo Fisher Scientific offers a wide range of services and products for genetic analysis, including sequencing, making it a competitor in the broader genetic testing and analysis market.

About

Invitae Corporation, a medical genetics company, integrates genetic information into healthcare decision-making by clinicians and patients in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and rare diseases. It serves patients, healthcare providers, biopharma companies, and other partners. It has a collaboration with Pacific Biosciences of California, Inc. to develop a production-scale high-throughput HiFi sequencing platform. The company was formerly known as Locus Development, Inc. and changed its name to Invitae Corporation in 2012. Invitae Corporation was founded in 2010 and is headquartered in San Francisco, California.
Show more...
CEO
Dr. Sean Emerson George Ph.D.
Employees
2600
Country
United States
ISIN
US46185L1035

Listings

MU
DE
IV8.MU

0 Comments

Share your thoughts

FAQ

What is Invitae stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Invitae stocks are traded under the ticker IV8.MU.
How many employees does Invitae have?▼
As of July 08, 2026, the company has 2,600 employees.
In which sector is Invitae located?▼
Invitae operates in the Health & Wellness sector.
When did Invitae complete a stock split?▼
Invitae has not had any recent stock splits.
Where is Invitae headquartered?▼
Invitae is headquartered in San Francisco, United States.